chrX-154379461-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_000117.3(EMD):c.-24C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000946 in 1,162,784 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 26)
Exomes 𝑓: 0.0000086 ( 0 hom. 5 hem. )
Consequence
EMD
NM_000117.3 5_prime_UTR
NM_000117.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.151
Genes affected
EMD (HGNC:3331): (emerin) Emerin is a serine-rich nuclear membrane protein and a member of the nuclear lamina-associated protein family. It mediates membrane anchorage to the cytoskeleton. Dreifuss-Emery muscular dystrophy is an X-linked inherited degenerative myopathy resulting from mutation in the emerin gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant X-154379461-C-T is Benign according to our data. Variant chrX-154379461-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 382185.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00000858 (9/1049022) while in subpopulation AMR AF= 0.000287 (8/27831). AF 95% confidence interval is 0.000143. There are 0 homozygotes in gnomad4_exome. There are 5 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EMD | NM_000117.3 | c.-24C>T | 5_prime_UTR_variant | 1/6 | ENST00000369842.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EMD | ENST00000369842.9 | c.-24C>T | 5_prime_UTR_variant | 1/6 | 1 | NM_000117.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000176 AC: 2AN: 113715Hom.: 0 Cov.: 26 AF XY: 0.0000279 AC XY: 1AN XY: 35869
GnomAD3 genomes
AF:
AC:
2
AN:
113715
Hom.:
Cov.:
26
AF XY:
AC XY:
1
AN XY:
35869
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000279 AC: 3AN: 107697Hom.: 0 AF XY: 0.0000538 AC XY: 2AN XY: 37155
GnomAD3 exomes
AF:
AC:
3
AN:
107697
Hom.:
AF XY:
AC XY:
2
AN XY:
37155
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000858 AC: 9AN: 1049022Hom.: 0 Cov.: 31 AF XY: 0.0000146 AC XY: 5AN XY: 342126
GnomAD4 exome
AF:
AC:
9
AN:
1049022
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
342126
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000176 AC: 2AN: 113762Hom.: 0 Cov.: 26 AF XY: 0.0000278 AC XY: 1AN XY: 35926
GnomAD4 genome
AF:
AC:
2
AN:
113762
Hom.:
Cov.:
26
AF XY:
AC XY:
1
AN XY:
35926
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 13, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at